MorphoSys AG (NASDAQ:MOR) Receives Average Recommendation of

MorphoSys AG (NASDAQ:MOR) Receives Average Recommendation of "Moderate Buy" from Brokerages

Shares of MorphoSys AG (NASDAQ:MOR – Get Free Report) have earned an average rating of “Moderate Buy” from the eight research firms that are presently covering the company, Marketbeat.com reports. One research analyst has rated the stock with a sell rating, two have given a hold rating and five have issued a buy rating on […]

Related Keywords

United States , , Goldman Sachs Group , Morgan Stanley , Marshall Wace , Morphosys Company Profile , T Rowe Price Investment Management Inc , Optiver Holding , Get Free Report , Rowe Price Investment Management , Global Management , Get Free , Morphosys Daily , Morphosys , Nasdaq Mor , Humor , Medical , Ratings , Consensus ,

© 2025 Vimarsana